← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2016Last known activity
Jan 31, 2025
Timeline
2010s
- Jun 1, 2016
Aptevo Therapeutics— Founded
Drugs by trial phase (12 distinct, 13 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT04973618Lead sponsorPhase 1Jan 31, 2025
- NCT06634394OfficialPhase 1Oct 1, 2024
- NCT06634394Lead sponsorPhase 1Oct 1, 2024
- NCT05934539Lead sponsorPhase 1/Phase 2Dec 23, 2022
- NCT03855280Lead sponsorPhase 3Aug 15, 2019
- NCT03855280Study chairPhase 3Aug 15, 2019
- NCT03768219Lead sponsorPhase 1Mar 18, 2019
- NCT03768219Overall official - principal investigatorPhase 1Mar 18, 2019
- NCT03647800Lead sponsorPhase 1Nov 15, 2018
- NCT03647800Study directorPhase 1Nov 15, 2018
- NCT02262910Lead sponsorPhase 1Jan 1, 2015
- NCT02262910Study directorPhase 1Jan 1, 2015
- NCT01644253Study directorPhase 1Sep 1, 2012
- NCT01644253Lead sponsorPhase 1Sep 1, 2012
- NCT01317901Lead sponsorPhase 1May 1, 2011
Details
- Founded
- Seattle, WA, US Jun 1, 2016
- Last known activity
- Jan 31, 2025